Palo Alto Investors’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q4 | – | Sell |
-855,713
| Closed | -$17.3M | – | 44 |
|
2021
Q3 | $17.3M | Buy |
855,713
+523,000
| +157% | +$10.5M | 1.04% | 21 |
|
2021
Q2 | $12.4M | Hold |
332,713
| – | – | 0.68% | 22 |
|
2021
Q1 | $8.51M | Buy |
332,713
+900
| +0.3% | +$23K | 0.48% | 24 |
|
2020
Q4 | $7.31M | Hold |
331,813
| – | – | 0.38% | 22 |
|
2020
Q3 | $5.97M | Hold |
331,813
| – | – | 0.33% | 23 |
|
2020
Q2 | $8.43M | Hold |
331,813
| – | – | 0.51% | 21 |
|
2020
Q1 | $6.1M | Hold |
331,813
| – | – | 0.51% | 23 |
|
2019
Q4 | $7.31M | Hold |
331,813
| – | – | 0.4% | 23 |
|
2019
Q3 | $4.77M | Hold |
331,813
| – | – | 0.32% | 25 |
|
2019
Q2 | $5.23M | Sell |
331,813
-169,100
| -34% | -$2.66M | 0.25% | 28 |
|
2019
Q1 | $7.34M | Hold |
500,913
| – | – | 0.31% | 28 |
|
2018
Q4 | $5.36M | Hold |
500,913
| – | – | 0.29% | 28 |
|
2018
Q3 | $7.64M | Hold |
500,913
| – | – | 0.31% | 27 |
|
2018
Q2 | $6.14M | Hold |
500,913
| – | – | 0.25% | 27 |
|
2018
Q1 | $4.79M | Hold |
500,913
| – | – | 0.2% | 27 |
|
2017
Q4 | $4.52M | Hold |
500,913
| – | – | 0.19% | 28 |
|
2017
Q3 | $2.88M | Hold |
500,913
| – | – | 0.12% | 29 |
|
2017
Q2 | $1.59M | Buy |
500,913
+19,394
| +4% | +$61.5K | 0.07% | 29 |
|
2017
Q1 | $1.64M | Buy |
481,519
+323,240
| +204% | +$1.1M | 0.08% | 29 |
|
2016
Q4 | $456K | Sell |
158,279
-109,611
| -41% | -$316K | 0.03% | 37 |
|
2016
Q3 | $1.58M | Hold |
267,890
| – | – | 0.09% | 33 |
|
2016
Q2 | $804K | Hold |
267,890
| – | – | 0.06% | 40 |
|
2016
Q1 | $1.44M | Hold |
267,890
| – | – | 0.11% | 36 |
|
2015
Q4 | $3.18M | Hold |
267,890
| – | – | 0.18% | 33 |
|
2015
Q3 | $2.2M | Buy |
267,890
+197,184
| +279% | +$1.62M | 0.11% | 36 |
|
2015
Q2 | $986K | Buy |
+70,706
| New | +$986K | 0.04% | 42 |
|